Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia
PHASE4CompletedINTERVENTIONAL
Enrollment
194
Participants
Timeline
Start Date
December 31, 2013
Primary Completion Date
December 31, 2016
Study Completion Date
August 31, 2017
Conditions
Neurogenic Lower Urinary Tract Dysfunction
Interventions
DRUG
Naftofidil
DRUG
Tamsulosin
Trial Locations (1)
130-710
Samsung Medical Center, Seoul
All Listed Sponsors
lead
Samsung Medical Center
OTHER
NCT02034604 - Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter